A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT ID: NCT00034905
Last Updated: 2013-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
2001-07-31
2002-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quetiapine Extended Release Depression Symptoms
NCT00640562
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00085891
Effect of Quetiapine on Negative Symptoms and Cognition
NCT00305422
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
NCT00600756
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
NCT00206115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quetiapine fumarate vs risperidone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Schizophrenia (as per DSM IV)
Exclusion Criteria
* Does not fulfill moderately ill on CGI
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Phoenix, Arizona, United States
Anaheim, California, United States
Cerritos, California, United States
Chula Vista, California, United States
Glendale, California, United States
Hawthorne, California, United States
Long Beach, California, United States
San Diego, California, United States
Santa Ana, California, United States
Torrance, California, United States
Farmington, Connecticut, United States
New Haven, Connecticut, United States
Washington D.C., District of Columbia, United States
Miami, Florida, United States
Miami Beach, Florida, United States
North Miami, Florida, United States
Winter Park, Florida, United States
Atlanta, Georgia, United States
Hoffman Estates, Illinois, United States
Prairie Village, Kansas, United States
Wichita, Kansas, United States
New Orleans, Louisiana, United States
Shreveport, Louisiana, United States
Baltimore, Maryland, United States
Boston, Massachusetts, United States
Worcester, Massachusetts, United States
Ann Arbor, Michigan, United States
New Baltimore, Michigan, United States
Kansas City, Missouri, United States
St Louis, Missouri, United States
Reno, Nevada, United States
Clementon, New Jersey, United States
Lyons, New Jersey, United States
Summit, New Jersey, United States
Albuquerque, New Mexico, United States
Holliswood, New York, United States
Montrose, New York, United States
New York, New York, United States
Oceanside, New York, United States
The Bronx, New York, United States
White Plains, New York, United States
Butner, North Carolina, United States
Beachwood, Ohio, United States
Chagrin Falls, Ohio, United States
Cincinnati, Ohio, United States
Columbus, Ohio, United States
Oklahoma City, Oklahoma, United States
Media, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Memphis, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Houston, Texas, United States
Terrell, Texas, United States
Waco, Texas, United States
Salt Lake City, Utah, United States
Falls Church, Virginia, United States
Richmond, Virginia, United States
Virginia Beach, Virginia, United States
Kirkland, Washington, United States
Tacoma, Washington, United States
Vancouver, Washington, United States
West Allis, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5077US/0043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.